cell locomotion
Recently Published Documents


TOTAL DOCUMENTS

179
(FIVE YEARS 7)

H-INDEX

46
(FIVE YEARS 1)

2021 ◽  
Vol 6 (10) ◽  
pp. 3608-3619
Author(s):  
Seung-Hoon Um ◽  
Jaehong Lee ◽  
In-Seok Song ◽  
Myoung-Ryul Ok ◽  
Yu-Chan Kim ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-15
Author(s):  
Tai-Hsin Tsai ◽  
Ann-Shung Lieu ◽  
Yi-Wen Wang ◽  
Sheau-Fang Yang ◽  
Yi-Chiang Hsu ◽  
...  

Background. Glioblastoma multiforme (GBM) is the most common malignant brain tumor in the world. Despite advances in surgical resection, radiotherapy, and chemotherapy, GBM continues to have a poor overall survival. CDDO (2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid), a synthetic triterpenoid, is an Nrf2 activator used to inhibit proliferation and induce differentiation and apoptosis in various cancer cells. One new trifluoroethylamide derivative of CDDO, RTA 404, has been found to have increased ability to cross the blood-brain barrier. However, it is not clear what effect it may have on tumorigenesis in GBM. Methods. This in vitro study evaluated the effects of RTA 404 on GBM cells. To do this, we treated GBM840 and U87 MG cell lines with RTA 404 and assessed apoptosis, cell cycle, cell locomotion, and senescence. DNA content and induction of apoptosis were analyzed by flow cytometry and protein expression by Western blot analysis. Results. RTA 404 significantly inhibited the proliferation of tumor cells at concentrations higher than 100 nM ( p < 0.05 ) and reduced their locomotion ability. In addition, treatment with RTA 404 led to an accumulation of RTA 404-treated G 2 / M phase cells and apoptosis. An analysis of the p21/AKT expression suggested that RTA 404 may not only help prevent brain cancer but it may also exert antitumor activities in established GBM cells. Conclusion. RTA404 can inhibit proliferation, cell locomotion, cell cycle progression, and induce apoptosis in GBM cells in vitro, possibly through its inhibition of N-cadherin and E-cadherin expression via its inhibition of the AKT pathway.


2020 ◽  
Vol 31 (15) ◽  
pp. 1637-1649 ◽  
Author(s):  
Calina Copos ◽  
Alex Mogilner

At the onset of cell locomotion, cells break symmetry to form well-defined cell fronts and rears through the process of cellular polarization. Using an in silico approach, we have identified one of the simplest quantitative frameworks as a possible mechanochemical mechanism for spontaneous cell polarization.


2020 ◽  
Vol 1 (2) ◽  
Author(s):  
David Caballero ◽  
Subhas C. Kundu ◽  
Rui L. Reis

ABSTRACT The concepts and frameworks of soft matter physics and the laws of thermodynamics can be used to describe relevant developmental, physiologic, and pathologic events in which directed cell migration is involved, such as in cancer. Typically, this directionality has been associated with the presence of soluble long-range gradients of a chemoattractant, synergizing with many other guidance cues to direct the motion of cells. In particular, physical inputs have been shown to strongly influence cell locomotion. However, this type of cue has been less explored despite the importance in biology. In this paper, we describe recent in vitro works at the interface between physics and biology, showing how the motion of cells can be directed by using gradient-free environments with repeated local asymmetries. This rectification of cell migration, from random to directed, is a process reminiscent of the Feynman ratchet; therefore, this framework can be used to explain the mechanism behind directed cell motion.


2020 ◽  
Vol 15 (3) ◽  
pp. 031001
Author(s):  
Xiufang Li ◽  
Qiang Zhang ◽  
Shuqin Yan ◽  
Mingzhong Li ◽  
Renchuan You

2020 ◽  
Vol 219 (3) ◽  
Author(s):  
Sandra Sofía Edwards-Jorquera ◽  
Floris Bosveld ◽  
Yohanns A. Bellaïche ◽  
Ana-María Lennon-Duménil ◽  
Álvaro Glavic

Phagocytes use their actomyosin cytoskeleton to migrate as well as to probe their environment by phagocytosis or macropinocytosis. Although migration and extracellular material uptake have been shown to be coupled in some immune cells, the mechanisms involved in such coupling are largely unknown. By combining time-lapse imaging with genetics, we here identify the lysosomal Ca2+ channel Trpml as an essential player in the coupling of cell locomotion and phagocytosis in hemocytes, the Drosophila macrophage-like immune cells. Trpml is needed for both hemocyte migration and phagocytic processing at distinct subcellular localizations: Trpml regulates hemocyte migration by controlling actomyosin contractility at the cell rear, whereas its role in phagocytic processing lies near the phagocytic cup in a myosin-independent fashion. We further highlight that Vamp7 also regulates phagocytic processing and locomotion but uses pathways distinct from those of Trpml. Our results suggest that multiple mechanisms may have emerged during evolution to couple phagocytic processing to cell migration and facilitate space exploration by immune cells.


Soft Matter ◽  
2020 ◽  
Vol 16 (12) ◽  
pp. 3106-3124 ◽  
Author(s):  
Aurore Loisy ◽  
Jens Eggers ◽  
Tanniemola B. Liverpool

Modelling a cell as a deformable drop of active matter, we classify the types of cell locomotion on solid surfaces based on general physical principles. Previous models are special cases of our framework and we identify a new self-propulsion mode.


2018 ◽  
Vol 19 (12) ◽  
pp. 3949 ◽  
Author(s):  
Pontus Aspenström

Involvement of Rho GTPases in cancer has been a matter of debate since the identification of the first members of this branch of the Ras superfamily of small GTPases. The Rho GTPases were ascribed important roles in the cell, although these were restricted to regulation of cytoskeletal dynamics, cell morphogenesis, and cell locomotion, with initially no clear indications of direct involvement in cancer progression. This paradigm has been challenged by numerous observations that Rho-regulated pathways are often dysregulated in cancers. More recently, identification of point mutants in the Rho GTPases Rac1, RhoA, and Cdc42 in human tumors has finally given rise to a new paradigm, and we can now state with confidence that Rho GTPases serve as oncogenes in several human cancers. This article provides an exposé of current knowledge of the roles of activated Rho GTPases in cancers.


2018 ◽  
Vol 19 (12) ◽  
pp. 3876 ◽  
Author(s):  
Vladimir Purvanov ◽  
Christoph Matti ◽  
Guerric P. B. Samson ◽  
Ilona Kindinger ◽  
Daniel F. Legler

Chemokines are essential guidance cues orchestrating cell migration in health and disease. Cognate chemokine receptors sense chemokine gradients over short distances to coordinate directional cell locomotion. The chemokines CCL19 and CCL21 are essential for recruiting CCR7-expressing dendritic cells bearing pathogen-derived antigens and lymphocytes to lymph nodes, where the two cell types meet to launch an adaptive immune response against the invading pathogen. CCR7-expressing cancer cells are also recruited by CCL19 and CCL21 to metastasize in lymphoid organs. In contrast, atypical chemokine receptors (ACKRs) do not transmit signals required for cell locomotion but scavenge chemokines. ACKR4 is crucial for internalizing and degrading CCL19 and CCL21 to establish local gradients, which are sensed by CCR7-expressing cells. Here, we describe the production of fluorescently tagged chemokines by fusing CCL19 and CCL21 to monomeric red fluorescent protein (mRFP). We show that purified CCL19-mRFP and CCL21-mRFP are versatile and powerful tools to study CCR7 and ACKR4 functions, such as receptor trafficking and chemokine scavenging, in a spatiotemporal fashion. We demonstrate that fluorescently tagged CCL19 and CCL21 permit the visualization and quantification of chemokine gradients in real time, while CCR7-expressing leukocytes and cancer cells sense the guidance cues and migrate along the chemokine gradients.


Sign in / Sign up

Export Citation Format

Share Document